Name | Number of supported studies | Average coverage | |
---|---|---|---|
neuron | 3 studies | 20% ± 3% | |
endothelial cell | 3 studies | 16% ± 1% | |
epithelial cell | 3 studies | 19% ± 3% |
Insufficient scRNA-seq data for expression of FXR2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3136.14 | 1445 / 1445 | 100% | 26.65 | 183 / 183 |
brain | 100% | 4380.64 | 2641 / 2642 | 100% | 54.24 | 705 / 705 |
skin | 100% | 2721.85 | 1808 / 1809 | 100% | 44.00 | 472 / 472 |
prostate | 100% | 3128.00 | 245 / 245 | 100% | 34.61 | 501 / 502 |
ovary | 100% | 2588.31 | 180 / 180 | 100% | 22.47 | 429 / 430 |
thymus | 100% | 2558.77 | 652 / 653 | 100% | 35.32 | 604 / 605 |
lung | 100% | 2690.22 | 577 / 578 | 100% | 27.51 | 1152 / 1155 |
uterus | 100% | 3078.82 | 170 / 170 | 100% | 31.11 | 457 / 459 |
intestine | 100% | 2926.54 | 966 / 966 | 99% | 21.75 | 524 / 527 |
breast | 100% | 2436.73 | 459 / 459 | 99% | 32.68 | 1110 / 1118 |
bladder | 100% | 3102.48 | 21 / 21 | 99% | 27.15 | 498 / 504 |
kidney | 100% | 2704.53 | 89 / 89 | 99% | 26.56 | 890 / 901 |
adrenal gland | 100% | 3665.57 | 258 / 258 | 99% | 39.61 | 227 / 230 |
stomach | 100% | 2196.22 | 359 / 359 | 99% | 20.95 | 282 / 286 |
liver | 100% | 1569.08 | 225 / 226 | 98% | 17.93 | 397 / 406 |
pancreas | 98% | 1180.72 | 321 / 328 | 99% | 24.93 | 177 / 178 |
adipose | 100% | 2479.87 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 38.43 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.96 | 29 / 29 |
muscle | 100% | 8984.92 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2362.90 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 33.00 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.67 | 1 / 1 |
blood vessel | 100% | 3096.39 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 5277.74 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 1438.15 | 838 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0099577 | Biological process | regulation of translation at presynapse, modulating synaptic transmission |
GO_0048170 | Biological process | positive regulation of long-term neuronal synaptic plasticity |
GO_0043488 | Biological process | regulation of mRNA stability |
GO_0051028 | Biological process | mRNA transport |
GO_0021542 | Biological process | dentate gyrus development |
GO_0061157 | Biological process | mRNA destabilization |
GO_0048513 | Biological process | animal organ development |
GO_0045727 | Biological process | positive regulation of translation |
GO_0098793 | Cellular component | presynapse |
GO_0016020 | Cellular component | membrane |
GO_0098794 | Cellular component | postsynapse |
GO_0043005 | Cellular component | neuron projection |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0045182 | Molecular function | translation regulator activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0003723 | Molecular function | RNA binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FXR2 |
Protein name | Alternative protein FXR2 FMR1 autosomal homolog 2 RNA-binding protein FXR2 (FXR2P) (FMR1 autosomal homolog 2) |
Synonyms | FMR1L2 |
Description | FUNCTION: mRNA-binding protein that acts as a regulator of mRNAs translation and/or stability, and which is required for adult hippocampal neurogenesis (By similarity). Specifically binds to AU-rich elements (AREs) in the 3'-UTR of target mRNAs (By similarity). Promotes formation of some phase-separated membraneless compartment by undergoing liquid-liquid phase separation upon binding to AREs-containing mRNAs: mRNAs storage into membraneless compartments regulates their translation and/or stability (By similarity). Acts as a regulator of adult hippocampal neurogenesis by regulating translation and/or stability of NOG mRNA, thereby preventing NOG protein expression in the dentate gyrus (By similarity). . |
Accessions | ENST00000704984.1 ENST00000250113.12 P51116 L0R4Y0 A0A994J7P9 ENST00000571597.1 I3L1Z2 |